Up next

Company Executives Outline Growth Strategies and Expansions at the DCAT Member Company Announcement Forum

In this special issue of DCAT Value Chain Insights, we are providing information that would have been presented at the DCAT Member Company Announcement Forum at DCAT Week ’20. Originally scheduled to be held on March 23 in New York, these announcements were selected by the Announcement Oversight Task Force, as they present the latest major company news impacting the pharmaceutical manufacturing value chain. CEOs and senior executives from DCAT member companies outline their companies’ growth strategies by providing updates on key mergers and acquisitions and expansions with news from the following companies: Cambrex, Recipharm, Thermo Fisher Scientific, Lonza, SK pharmteco, Catalent, Biocon, CordenPharma, and WuXi STA. The individual news developments are outlined below.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Feature Articles

Lilly Continues Biotech Acquisition Spree

By
Lilly has been active on the M&A front with a series of biotech acquisitions totaling up to more than $20 billion in 2026 to date  What moves are the company making?

Shoring up API Mfg & Supply in Europe

By
European policymakers reached a provisional agreement on the Critical Medicines Act, designed to strengthen the EU’s pharma manufacturing base. What is next?

FDA: The Changing of the Guard: What May Be Next?

By
Dr. Marty Makary stepped down this week as FDA Commissioner, marking the latest leadership change at the agency. What may be the policy implications for such a move?

What’s Trending: Small-Molecule Drugs

By
How are small-molecule drugs faring in new drug approvals by FDA and among potential blockbuster contenders? DCAT Value Chain Insights takes an inside look.